UNIVERSE PHARMACEUTICAL-CL A (UPC) Stock Price & Overview
NASDAQ:UPC • KYG9442G1385
The current stock price of UPC is 2.43 USD. Today UPC is down by -3.19%. In the past month the price decreased by -33.42%. In the past year, price decreased by -39.08%.
UPC Key Statistics
- Market Cap
- 1.361M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -10.13
- Dividend Yield
- N/A
UPC Stock Performance
UPC Stock Chart
UPC Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to UPC. When comparing the yearly performance of all stocks, UPC is a bad performer in the overall market: 91.74% of all stocks are doing better.
UPC Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to UPC. While UPC seems to be doing ok healthwise, there are quite some concerns on its profitability.
UPC Earnings
UPC Forecast & Estimates
UPC Groups
Sector & Classification
UPC Financial Highlights
Over the last trailing twelve months UPC reported a non-GAAP Earnings per Share(EPS) of -10.13. The EPS increased by 99.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.3% | ||
| ROE | -6.54% | ||
| Debt/Equity | 0.13 |
UPC Ownership
UPC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 27.97 | 943.209B | ||
| JNJ | JOHNSON & JOHNSON | 20.88 | 585.582B | ||
| MRK | MERCK & CO. INC. | 22.43 | 287.316B | ||
| PFE | PFIZER INC | 9.01 | 155.235B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.32 | 122.147B | ||
| ZTS | ZOETIS INC | 16.33 | 50.567B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.89 | 26.934B | ||
| VTRS | VIATRIS INC | 5.52 | 16.085B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.48 | 11.659B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.158B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.518B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.968B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.8 | 4.412B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About UPC
Company Profile
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
Company Info
IPO: 2021-03-23
UNIVERSE PHARMACEUTICAL-CL A
265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone
Ji'an JIANGXI CN
Employees: 216
Phone: 867968403309
UNIVERSE PHARMACEUTICAL-CL A / UPC FAQ
What does UNIVERSE PHARMACEUTICAL-CL A do?
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
Can you provide the latest stock price for UNIVERSE PHARMACEUTICAL-CL A?
The current stock price of UPC is 2.43 USD. The price decreased by -3.19% in the last trading session.
Does UNIVERSE PHARMACEUTICAL-CL A pay dividends?
UPC does not pay a dividend.
What is the ChartMill technical and fundamental rating of UPC stock?
UPC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for UNIVERSE PHARMACEUTICAL-CL A?
UNIVERSE PHARMACEUTICAL-CL A (UPC) operates in the Health Care sector and the Pharmaceuticals industry.
What is the market capitalization of UPC stock?
UNIVERSE PHARMACEUTICAL-CL A (UPC) has a market capitalization of 1.36M USD. This makes UPC a Nano Cap stock.
Who owns UNIVERSE PHARMACEUTICAL-CL A?
You can find the ownership structure of UNIVERSE PHARMACEUTICAL-CL A (UPC) on the Ownership tab.